Company Monitoring Page for Amgen

job ratings (see below graph) for Amgen

latest headlines for company on cafepharma

Amgen asks Supreme Court to take up its high-profile PCSK9 patent case against Sanofi and Regeneron
Fierce Pharma
Mon, 11/29/21 - 10:44 pm
Tags:
Amgen, Sanofi, Regeneron, patents, Supreme Court, Repatha
Amgen's Otezla, Repatha and biosimilars put on notice, with challenging years ahead
Fierce Pharma
Mon, 11/22/21 - 10:13 pm
Tags:
Amgen, biosimilars, Otezla, Repatha
Amgen, Biohaven, Lilly and Teva plowed plenty into marketing migraine meds. Is it working?
Fierce Pharma
Mon, 11/22/21 - 10:21 am
Tags:
migraines, pharma marketing, JNJ, Topamax, Amgen, Biohaven, Eli Lilly, Teva Pharmaceutical
Merck’s Anti-Cholesterol Drug Threatens Esperion, Other PCSK9 Inhibitor Makers
BioSpace
Mon, 11/15/21 - 11:55 pm
Tags:
Merck, PCSK9 inhibitors, Amgen, Repatha, Esperion, Sanofi, Regeneron, Praluent
Seeking an edge over Amgen, Mirati advances lower KRAS dose in Keytruda combo to improve tolerability
Fierce Biotech
Tue, 11/9/21 - 10:49 am
Tags:
Mirati Therapeutics, Amgen, KRAS, clinical trials, Merck, Keytruda
Amgen breaks ground on New Albany, OH manufacturing plant of the future — report
Endpoints
Fri, 11/5/21 - 09:53 am
Tags:
Amgen, drug manufacturing, Ohio
Why did FDA ask Amgen to add low-dose trial of Lumakras?
Korea Biomed
Wed, 11/3/21 - 10:47 am
Tags:
FDA, Amgen, clinical trials, Lumakras, oncology, cancer
A three-decade monopoly: How Amgen built a patent thicket around its top-selling drug
BioPharma Dive
Mon, 11/1/21 - 11:56 am
Tags:
Amgen, Enbrel, rheumatoid arthritis, patents
Buckle up AbbVie, Amgen: Biohaven's oral CGRP drug is gaining traction in migraine, doctors’ survey shows
Fierce Pharma
Fri, 10/22/21 - 12:42 pm
Tags:
Biohaven, migraines, Nurtec ODT, Amgen, AbbVie
Amid Amgen's similar struggles, AstraZeneca slams the brakes on MCL-1 blood cancer drug
Fierce Biotech
Wed, 10/20/21 - 10:20 am
Tags:
AstraZeneca, AZD5991, clinical trials, Amgen, blood cancer
Allied with Amgen and backed by $500M, Neumora brings data science to brain drugs
MedCity News
Thu, 10/7/21 - 12:19 pm
Tags:
Neumora Therapeutics, R&D, Amgen, funding, data science, drug development
Bristol Myers Squibb's deucravacitinib flunks midphase IBD trial, raising questions about potential blockbuster
Fierce Biotech
Thu, 10/7/21 - 11:24 am
Tags:
Bristol Myers Squibb, deucravacitinib, Amgen, Otzela, psoriasis, ulcerative colitis
Biopharma needs a biggie to avoid a down deal year
EP Vantage
Thu, 10/7/21 - 11:07 am
Tags:
M&A, Merck, Acceleron, Sanofi, Translate Bio, Amgen, Teneobio, Pfizer, Trillium, Perrigo, HRA Pharma
Amgen reveals midphase eczema data behind its $400M bet
Fierce Biotech
Mon, 10/4/21 - 10:38 am
Tags:
Amgen, Kyowa Kirin, clinical trials, eczema, antibodies
Amgen receives FDA approval for Repatha to treat pediatric HeFH patients
Pharmaceutical Business Review
Mon, 09/27/21 - 11:00 am
Tags:
Amgen, Repatha, FDA, pediatric, HeFH
Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028
Fierce Pharma
Tue, 09/21/21 - 10:54 am
Tags:
Amgen, Otezla, psoriasis, generics, Sandoz, market exclusivity, patents
ESMO: Mirati pulls away from Amgen in colorectal cancer with rival KRAS drug
Fierce Biotech
Mon, 09/20/21 - 12:00 am
Tags:
ESMO, Mirati Therapeutics, Amgen, colorectal cancer
Amgen to advance KRAS drug combination after improved results in colon cancer
BioPharma
Thu, 09/16/21 - 10:40 pm
Tags:
Amgen, Lumakras, clinical trials, colon cancer
ESMO Preview: Highlights to Watch for This Year
BioSpace
Wed, 09/15/21 - 10:29 pm
Tags:
ESMO, oncology, cancer, Gilead Sciences, Bristol Myers Squibb, Zymeworks, Amgen, Adaptimmune Therapeutics, TCR2 Therapeutics, Boehringer Ingelheim
ESMO 2021 – Mirati bids to be belle of the ball
EP Vantage
Tue, 09/14/21 - 10:41 am
Tags:
ESMO, Mirati Therapeutics, Faron Pharmaceuticals, Amgen, Spectrum Pharmaceuticals

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.